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Abstract 
 
Multiple modalities of cognitive stimulation (CS) have been designed and tested in samples of patients with 
SUREDEOH$O]KHLPHU¶VGLVHDVH (AD). Despite the substantial inter-study variability, an overall positive impact of 
CS is reported. This impact has been especially observed in general measures of cognition. The mechanisms by 
which cognitive exercises would be beneficial for high-order cortical functions are still largely undetermined, 
however. 
 
When CS has been applied to patients with Mild Cognitive Impairment (who are at the prodromal stage of AD) 
more stringent methodological criteria and designs were used and studies have been of greater clinical and 
research relevance. At this disease stage, a positive impact of CS has been reported in a range of different 
cognitive domains, and even at a neuro-computational level by the measurement of test-retest modifications of 
brain function. 
 
The effects of CS in healthy adults have also been studied. This population allows researchers to explore and 
test specific neural mechanisms possibly underlying the effect of pen-and-paper or computerised exercises. The 
evidence from these studies and those contributing to a better understanding of the pathophysiology of AD has 
led to devising forms of CS as preventive and therapeutical measures for neurodegenerative diseases based on 
novel frameworks of brain structure, function and connectivity. 
 
An extensive review of the literature was carried out to clarify whether CS is effective in AD and mild cognitive 
impairment and, together with the evidence from studies in healthy participants, to identify the relevant 
mechanisms that might sustain this effectiveness. 
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Introduction 
 
$O]KHLPHU¶VGLVHDVH$'LVa neurodegenerative condition associated with multidimensional de-regulation of 
neurobiological and neurobehavioural variables [1]. Although no decisive treatment for AD is available at 
present, the study of therapeutics is a vast frontier of research that is addressing the scarcity of findings with 
translational applicability to clinical settings. One major area of investigation is represented by non-
pharmacological interventions based on pen-and-paper or computerised exercises with significant computational 
demands, and specifically designed to improve cerebral and cognitive parameters. This type of approach is 
normally indicated as ³FRJQLWLYHVWLPXODWLRQ´&6, although other labels have been sometimes proposed (e.g. 
³FRJQLWLYHWUDLQLQJ´RU³FRJQLWLYHUHKDELOLWDWLRQ´, depending on the distinct theoretical purpose that may drive 
the design of a programme of intervention [2-4].  
 
Observational studies carried out on large cohorts have reported that engaging in various types of cognitive 
activities is protective against the onset of AD later in life [5-8]. These findings are statistically robust, as they 
derive from longitudinal designs and the recruitment of remarkably large samples. However, they also suffer 
from significant methodological limitations associated with the inability to manipulate the independent variables 
in observational designs (above all, the inability to define a statistical cause and effect relationship between CS 
and cognitive benefit). In this respect, clinical trials represent a valuable complementary source of evidence. 
While the number of participants included in such studies is more limited, research teams can manipulate CS in 
accordance with their experimental hypothesis. 
 
Although other publications have reviewed the available experimental evidence of published trials of CS in 
relation with a diagnosis of AD [2, 9], to our knowledge no reviews have covered the literature on CS in 
association with a model of AD that accounts for the progression of the pathology from the preclinical stage 
onwards, and includes neuroimaging markers. Neuroimaging measures are gaining more and more attention in 
the characterisation of AD neurodegeneration in ageing. The main reason behind this lies in the profound 
association that appears to exist between the neurobiology of this neurodegenerative disease and measures of 
brain atrophy and functional connectivity [10]. In AD, in fact, the Beta Amyloid neurotoxic plaques tend to 
accumulate following a regional distribution that overlaps with the default-mode network [11], a brain network 
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that activates in the absence of explicit mental tasks. Based on this, measures of neuroimaging might become an 
important marker of treatment effects of CS, similarly to the way they can track down the impact of 
pharmacological treatment [12-14]. Our objective was, therefore, to summarise the main experimental findings 
in this research field, with particular focus on the timeline of AD and on its neural involvement. Dementia is the 
most prominent cognitive feature of later-stage AD. However, it is important to highlight that in this review we 
did not include papers that report studies carried out on patients having a general form of dementia, unless 
necessary for the purpose of describing methodological aspects. The reason behind this choice lies in the fact 
that multiple aetiologies may contribute to a diagnosis of dementia [15]. Although the cognitive phenotype of 
two forms of dementia may be equivalent, the underlying neural and patho-physiological mechanisms of distinct 
diagnostic entities are considerably different. For this reason, the identification of a robust framework to 
operationalise CS requires a critical review of evidence collected in a set of studies carried out on a 
homogeneous population of individuals whose recruitment is based on recognised criteria for AD [16-17]. Since 
the main objective of this study was reviewing the mechanisms of CS in AD, studies focusing on treatments 
specifically designed for patient-caregiver dyads or based on interventions of profound non-cognitive signatures 
were not included.   
 
 
Part 1: Cognitive Stimulation in the Presence of a Diagnosis of Clinically Established AlzheLPHU¶V'LVHDVH 
 
It is clear that CS does not represent a unitary entity, and meta-analytical procedures do not capture this 
heterogeneity. Cochrane criteria were used to meta-analyse the effectiveness of CS trials in early-stage [18] and 
mild-to-moderate AD [19]. Both systematic studies featured stringent methodologies and both studies reported 
no impact of CS on cognitive abilities. Conversely, a third meta-analysis featuring less strict constraints for 
inclusion in the analysis revealed that CS exerts beneficial effects over learning and executive functions in AD 
patients [20]. The trade-off between compliance to methodological rigidity and evidence of an effect suggests 
that there must be several studies that suffer from design shortcomings. The reason behind these shortcomings 
may be found in the medical background of AD patients. Unfortunately, patients diagnosed with clinically-
established dementia of AD type also have multiple problematic aspects in their medical, familiar, and 
psychosocial histories. In this respect, breaches of methodological rigidity are a necessary evil in the quest for a 
compromise between clinical obligations and the experimental study of the topic. A control group (or condition) 
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is very often absent, and it is frequently impossible to separate the effect of CS from that of other forms of 
concurrent pharmacological or non-pharmacological treatment (which might, in turn, show intra-sample 
variability, for instance with regard to drug type or dosage). Although the presence of methodological 
shortcomings in an experimental design might compromise the scientific rigour of its findings, it has to be 
acknowledged that this field of research is still in its early stages, and no well-established pattern of findings or 
methodological gold-standard exists. For this reason any study may be informative and useful in the definition 
of potential candidate CS mechanisms, test-retest indices of treatment effectiveness and CS features 
(programme duration, session duration and intensity, definition of the exercises, difficulty levels, multimedial 
implementation, individual vs group training, etc.). As a consequence, an extensive review of a large number of 
studies would represent a complimentary overview to other reviews and meta-analyses that have focused 
exclusively on studies abiding by strict methodology. Moreover, the inclusion in the review of exploratory 
studies and of studies which are less strong methodologically offers the opportunity to give a comprehensive 
overview of this research field and not just a more restrictive perspective delimited by a small number of 
reviewed studies. 
The first section of studies reviewed in Part 1 will introduce a set of studies in which CS aimed to exercise 
aspects of cognition of extremely basic importance (i.e.. orientation in space and time). In the subsequent 
section the methodological issue of separating the impact of CS from that of concurrent types of interventions 
(i.e. pharmacological medication) will be introduced. Following that, specific focus will be given first to studies 
in which the additive effects of CS and pharmacological stimulation were investigated, and then to those in 
which the control group received medication treatment together with a control CS. The final section will 
examine in depth the research paradigms based on hypothesis that take into account the notion of 
neuroplasticity. 
 
Engaging in everyday activities which require a substantial computational load is associated with slower 
cognitive decline, when AD has been already diagnosed [21]. Often programmes of CS have been 
operationalised as sets of exercises aiming at enhancing those aspects of cognition that are still open to change. 
Reality Orientation Therapy (ROT), for example, is a stimulation technique that focuses on the sense of reality 
of the patient, who may have lost their orientation in space and time. The aim of ROT is reorienting constantly 
the patient in space and time, providing the person also with some memory information related to themselves. 
This type of stimulation is extremely basic, and is beneficial for patients diagnosed with various forms of 
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dementia [21-24]. Arguably, ROT does not involve considerable high-order cognitive aspects (like memory 
retrieval or executive processes). This reflects the first main problematic aspect of CS designed for and 
administered to samples of fully demented AD patients: the lack of training exercises strongly associated with 
skills that are strictly cognitive in nature. The conceptualisation of CS as exercises based on ³FRORXULQJDQG
GUDZLQJ´ [25]³ZDOW]-lessons´[26] RU³the game of %LQJR´ [27] takes a highly pragmatic approach to 
programmes of non pharmacological treatment.  Patients may fully engage in these exercises, but at the same 
time such tasks present indeterminate processing demands and have questionable reference to models of cortical 
cognitive functions like memory or executive abilities. There is a further problem with such approaches. The 
improvement associated with CS in samples of demented patients often has been studied just as a function of a 
change in general measures of cognition, with no focus on specific functions. In the following paragraphs 
studies of CS in AD will be reviewed in detail (see Table 1 for an overview).  
 
- Insert Table 1 about here - 
 
A programme which aimed to stimulate those cognitive skills which were still spared was administered to a 
sample of moderate-severe AD patients (with a Global-Deterioration-Scale (GDS) score of 5-6) over a 2 year 
period.  No improvement was detected [28]. In the same study, patients with GDS scores of 3-4 (thus 
classifiable as minimal-mild AD) were trained with exercises targeting various cognitive functions and activities 
of daily living. Again, no improvements in cognitive abilities were registered [28]. A similar experimental 
attempt was made by Farina and colleagues [29-30], who piloted a protocol of CS targeting ³UHVLGXDOFRJQLWLYH
IXQFWLRQV´ in a sample of mild-to-moderate AD. Again, no improvements of specific cognitive abilities 
emerged. Multicomponential non-pharmacological stimulation (including CS) was administered to a group of 10 
mild AD in a third research study. This led to no significant impact on either verbal or visuospatial memory 
[31]. These were the only cognitive components investigated in this study. In an additional study, mildly-
moderately demented ex-career soldiers with AD were assigned either to a stimulation of various cognitive 
functions or to a control group involved only in stimulation through communication. Although this study 
included methodological control, no specific cognitive testing was performed except for the general Mini-
Mental State Examination (MMSE), which showed a significant improvement triggered by CS [32]. 
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No mention of concomitant pharmacological treatment was made in the studies by Yanguas et al. [28], Farina et 
al. [29] and Kurz et al. [31]. In the other study by Farina and colleagues [30] part of the sample had treatment 
with a cholinergic enhancer, while with Niu and colleagues [32] all patients were receiving cholinesterase 
inhibitors. Although the study of CS in the presence of a diagnosis of AD is usually driven by an interest in the 
clinical efficacy of the treatment rather than in the understanding of the mechanisms that lead to positive 
changes, it is important to estimate at least the extent to which CS contributes to any improvements when CS is 
only one component of a multimodal treatment. The use of cholinergic treatment for AD is based on specific 
hypotheses and is associated to an extensive literature that has described the specific changes at a neural level in 
patients with AD [12-14]. In contrast, the mechanisms of CS are not fully known. For this reason it is important 
to take into account any variable that can account for changes in cognitive abilities, and discuss the results 
carefully, without omitting any potential cause of benefit. Paradoxically, in the five studies previously reported, 
the concurrent administration of CS and pharmacological treatment were interpreted in terms of benefit from the 
non pharmacological stimulation (CS), the mechanisms of which are even less understood. 
 
Other papers have described the effects of a combination of the two types of treatment (pharmacological and 
CS) administered together. In these studies two treatment options were compared, and both groups 
(experimental and control) were exclusively composed of patients having pharmacological therapy. The 
combination of drugs and ROT was tested by Giordano et al. [33] in a sample of mild-to-moderate AD. The 
authors reported a beneficial effect of this treatment regime on the FRJQLWLYHVXEVFDOHRIWKH$O]KHLPHU¶V
Disease Assessment Scale (ADAS-COG) score after 3 weeks, in comparison with the control group who 
received only pharmacological treatment. A more elaborate CS protocol was designed by Bottino and coworkers 
[34]. They recruited a mild, pharmacologically-treated, AD sample, who engaged in 5 months of various types 
of exercise, including ROT, errorless learning, communication and training of activities of daily living. The 
experimental group obtained improvement in the MMSE score and the digit span backwards when compared 
with the drug-only group. Further studies did not include ROT but were centred on other paradigms of CS. A 
study of cognitive-communication training was carried out by Chapman and colleagues [35]. After 2 months of 
treatment, mild-to-moderate AD individuals in the experimental group showed no improvement in either the 
MMSE, or the ADAS-COG score when compared with controls. Another study similarly centred on 
communication, but which also involved learning exercises and verbal fluency tasks was completed in Japan 
[36]. A small sample of AD patients was split into an experimental group based on this mixed treatment and 
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donepezil therapy and a drug-only condition. After 20 sessions (first administered at a weekly rate, then one 
session every two weeks) a significant group-by-time interaction revealed a positive synergic effect of 
medication and CS on MMSE scores [36]. The same pattern of findings was replicated in a shorter intervention, 
with only a 30-minute session of specific exercises for seven weeks [37]. A programme more focused on high-
order cognitive skills, rather than orientation or communication was published in Spanish. Following 
intervention with stimulation which focused on reasoning, attention, memory, language, calculation, praxis and 
gnosis a group of mild AD (mean MMSE at baseline: 22.89) showed benefits in verbal learning and fluency 
tests when compared with drug-only controls (baseline mean MMSE score: 20.12) [38]. In a more recent 
controlled trial the marketed videogame Big Brain Academy (Nintendo) was used as the CS programme with 
mild AD patients for 3 months. A significant increase in ADAS-COG score (indicating decline) was found at 
follow up in the control group; in the experimental group ADAS-COG scores remained stable [39]. In a recent 
study, a group of  mild AD patients were assigned either to a control condition only receiving medication or to 
one of two experimental groups in which medication was combined with working-memory training. The first of 
the two programmes consisted of exercises of manipulation of complex material, whereas the second one was 
based on a model of executive functions having a dynamic-psychology signature. After 6 months, an effect of 
condition was found for measures of daily-life activities, language, memory and executive functions, although 
the post-hRFFRPSDULVRQVLQGLFDWHGWKDWWKH³G\QDPLF´WUDLQLQJWULJJHUHGWKHODUJHVWEHQHILW'HVSLWHWKH
promising results, the authors highlighted that the sample included in this study was unfortunately characterised 
by lack of homogeneity in test performance at both baseline and retest [40]. All these studies included a control 
group whose members did not engage in any CS but only received pharmacological treatment. 
 
There are other studies that have reported a different type of experimental-control comparison, with controls 
receiving medication and also engaging in a control CS. A paper published more than 10 years ago described a 
randomised controlled trial in which an experimental group received 6 weeks of a previously published CS 
programme based on memory strategies [41] and was compared with a control group exposed to educational 
material. All patients recruited were on pharmacological treatment and the mean MMSE score of the two groups 
was 24 and 25, respectively, indicating very mild AD. No significant impact of the training was found on any of 
the measures of cognition investigated [42]. Löwenstein and colleagues [43] recruited mild AD patients under 
cholinergic treatment and assigned them either to an experimental group who trained with exercises of memory, 
attention, mental calculation, decision making and spatial-temporal orientation, or to a control group who 
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exercised with recreational activities. After 3 months the experimental group showed a significant improvement 
in verbal long-term memory, and the group-by-time interaction revealed a beneficial effect on the MMSE score. 
Tarraga and colleagues [44] trained mild AD participants for 3 months with a multidimensional programme 
including cholinesterase inhibitors, various forms of non-pharmacological treatments, and multimedia CS 
³6PDUWEUDLQ´WRROKWWSZZZHGXFDPLJRVFRP. The authors reported slight, yet significant, drug-exercise 
synergic benefits on global measures of cognition in comparison with a control group that received all forms of 
stimulation but did not engage in their computerised CS exercises. None of the tests which assessed specific 
cognitive skills rather than general cognitive levels were affected by the treatment. This was the first study 
among those so far described that introduced the use of computerised CS in samples of AD patients. A recent 
study focused on the additional benefits from computerised CS in a group of prodromal-to-mild AD patients in 
addition to ordinary pen-and-paper CS, in comparison with a group receiving pen-and-paper CS only. The 
authors reported no significant differences in cognitive functioning between the two groups after treatment [45]. 
 
We have reviewed 17 studies which report the findings of CS intervention in samples of patients with clinical 
AD dementia. A variety of interventions were described, such as ROT, communication training, exercises 
focused on high-order cognitive skills, pen-and-paper treatments, computerised programmes, commercialised 
videogames. Variability in methodological control was observed, as was variability in concurrent 
pharmacological treatment. Baseline disease severity levels were also heterogeneous. Overall, however, there is 
converging evidence which suggests that CS exerts some benefits in AD, at least in general measures of 
cognition. 
 
More recent studies have introduced a novel, computerised implementation of cognitive tasks. Tasks of this type 
may offer a number of important advantages (e.g. for adjustment of difficulty levels, the opportunity to convert 
CS into home-based telemedicine, the concurrent treatment of multiple participants at the same time despite the 
individual nature of the treatment). However, we believe that it does not represent the kind of breakthrough in 
the study of CS that transcends classic pen-and-paper CS. All studies characterise CS as an instrument designed 
to improve the clinical status of the patients (either with or without technological support), but rarely describe 
the mechanisms by which engaging in pen-and-paper or computerised cognitive stimulation would result in 
some sort of computational modulation. We suggest that the most crucial problem in the study of CS in clinical 
AD does not stem from any of the methodological shortcomings identified in the earlier literature. We would 
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suggest that the main issue in this area of research is the absence of an adequate interpretational framework 
capable of operationalising the disease and CS. An appropriate framework would indicate what measures of 
test-retest changes have to be analysed to test the experimental hypotheses, and would also suggest how to 
design the exercises of CS. At present, the exact mechanisms by which CS should be effective and beneficial are 
unknown. More research is needed to study the specific mechanisms by which behaviours may translate into 
neurobiological changes, which can alter the progression of the disease. The often tacit rationale by which the 
proposed exercises are meant to benefit cognitive functions in AD is based on a model according to which the 
simple exercise of cognitive functions will lead to improvement. The mechanisms by which exercising in one or 
more tasks improves the performance in trained and/or untrained tasks refer to the concepts of practice effect 
and transfer [46]. However, a cognitive framework is not the sole option to approach CS in the presence of a 
neurodegenerative disease. On a theoretical level CS is often associated and compared with physical activity, as 
both types of stimulation have been investigated in association with normal and abnormal ageing. However, 
whereas specific physiological mechanisms have been put forward to study the benefits of physical exercise 
[47], CS has been rarely studied with a similar approach. The study of animal models show that CS 
(conceptualised as environmental enrichment) triggers neurogenic benefits such as adult neurogenesis and 
cellular proliferation [48]. Such cellular mechanisms cannot be studied in vivo in a human model, but alternative 
variables can be investigated. Modern techniques of neuroimage acquisition and analysis offer the chance to 
study measures of brain structure and brain function, and to hypothesise and test mechanisms by which CS may 
have a specific impact on these measures. This theoretical chance is particularly relevant in AD because AD is 
associated with known patterns of structural and functional modifications of the brain, which could be targeted 
and slowed down, stopped or perhaps even reverted by CS. AD is a pathology that causes progressive and 
unstoppable neurodegeneration and deregulation of brain signal [49-51]. More sophisticated knowledge of the 
characteristics of brain structure and function in the various stages of AD pathology yields important 
information about the areas and connections of the brain that are fully, partially, or not functional when AD 
patients have entered the stage of dementia. As a consequence, it seems possible to design a programme of CS 
based on objectives determined by looking at the status of brain connectivity, and by choosing exercises that tap 
the desired target regions. Experimental hypotheses based on this framework have been scarce. There have been 
some studies that have looked at task-associated fMRI paradigms as a vehicle to evaluate treatment effects [52], 
but we are aware of only 2 studies that have investigated the effect of CS designed based on evidence of brain 
function in established AD dementia. In a paper published relatively early for this type of approach, a 
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programme of CS has been described by a Japanese team [53]. They recruited a small sample of patients 
diagnosed with AD of variable severity and assigned them either to a no-contact control group or to a training 
programme consisting of reading and simple arithmetic. The purpose of the exercises was to enhance activation 
in dorsolateral prefrontal cortex, parietal and temporal areas, the main regions in which hypometabolism is 
detected in AD [54]. After 6 months of training the experimental group showed a significant improvement in the 
Frontal Assessment Battery and stable MMSE scores, which declined in the controls [53]. Seven years later, an 
Italian team enrolled minimal-to-mild AD patients in a pen-and-paper intervention based on a specific 
hypothesis. They stimulated lexical-semantic abilities in order to regulate brain networks involved in verbal 
processing and semantic memory. After 3 months an improvement was registered in measures of global 
cognition, verbal skills, and long-term memory, in comparison with the control group, who engaged in a 
programme stimulating creativeness [55]. This study is also paradigmatic because none of the participants were 
having pharmacological treatment, and the benefits were not a synergic effect of drug and CS. 
 
The overall conclusion that we draw from the multifaceted literature on CS in AD dementia indicates that CS 
interventions result in sporadic moderate improvements in general measures of cognition. Studies have been 
often constructed in an exploratory fashion, without a specific rationale based on structural and functional 
progression of neurodegeneration in AD. The only two studies stemming from rationales based on neuroimaging 
suggest that this avenue of research deserves more attention. In addition, remarkably time-consuming 
programmes of CS do not induce dramatic benefits in cognitive skills. Most of the studies consisted of 
programmes of several weeks, and the improvements are limited to one or a few, often global, measures of 
cognition. While these changes may be significant from a statistical perspective, they do not always reflect a 
substantial improvement in clinical variables related to everyday life. The simplest explanation for the 
disappointing outcome of any cost-benefit qualitative analysis, suggests that AD-dementia is too late a stage for 
obtaining meaningful positive changes against the advance of neurodegeneration and breakdown of 
connectivity. This unavoidable conclusion is actually supported by disease models which account for the nature 
of neural modifications observed in AD. $FFRUGLQJWR0HVXODP¶VWKHRU\>6], the disruptive propagation of AD 
pathology in the brain is counteracted by mechanisms of structural and circuital rearrangement of compensatory 
nature. These PHFKDQLVPVDUHLQGLFDWHGDV³QHXURSODVWLFLW\´DQGwould be largely succesful during the early 
stages of the disease as long as the neuronal de-regulation is limited, but would become less and less effective 
and even maladaptively detrimental as the disease progresses through its later stages. According to this view, 
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any experimental or clinical attempt to trigger neuroplasticity during the dementia stage of AD would be largely 
ineffective. This, however, does not rule out the possibility of cognitive improvement or slower cognitive 
decline through non-neuroplastic mechanisms. In a detailed theoretical framework, Lövdén and colleagues set 
some specific boundaries to distinguish neuroplastic from non-neuroplastic changes in brain function and 
cognitive function: a change is promoted by neuroplasticity only when it is implemented by structural 
modifications (e.g. alteration of connections, neurogenesis, axonal growth) [57]. On the other hand, examples of 
non-neuroplastic phenomena are transient changes in intra/intercellular processes (e.g release of 
neurotransmitter or action potentials), or enhanced flexibility in the use of mental representations [57]. This 
latter form of computational change will be further discussed in Part 2 in association with the use of cognitive 
strategies as form of CS. Referring back to the idea of progressive failure of neuroplasticity observed in AD, 
interventions administered at an earlier stage of the disease would occur in a context of a greater residual 
capacity for neuroplastic responsiveness, and therefore would be more likely to have positive and lasting effects 
on cognition. 
 
 
Part 2: Cognitive Stimulation in the Presence of a Diagnosis of Mild Cognitive Impairment 
 
Common models describing the timeline of AD biomarkers depict the prodromal stage of AD as characterised 
by the absence of dementia, but detection of cognitive deficits in one or more domains [1]. This cognitive 
phenotype is labelled as Mild Cognitive Impairment (MCI). A patient with MCI has objective impairment in one 
or more aspects of cognition (often accompanied by subjective complaints) without dementia, and retains 
everyday life independence [58]. AD is only one of the possible underlying aetiologies of MCI [59] and for this 
reason there is no automatic correspondence between MCI and AD. This means that MCI patients with an 
amnestic phenotype (which, theoretically, might predicts future conversion to AD dementia) do not necessarily 
convert to AD dementia and, vice versa, non-amnestic MCI might convert to AD dementia [60]. This suggests 
that the population of MCI patients is quite heterogeneous with regard to the neural and cognitive status, and, 
therefore it might have a heterogeneous response to CS, whatever the rationale of the exercises is. Nonetheless, 
despite this large expected variability, it is of some value to review the main findings associated with CS in 
samples of MCI (See Table 1 for an overview). Similarly to Part 1, Part 2 is also subdivided into sections. The 
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first part will cover the use of mental strategy as a form of CS, while the second part will focus on CS 
programmes aimed to stimulate and enhance specific computational processes. 
 
MCI individuals are still independent in their daily life activities, and for this reason their clinical problems are 
not as severe as those experienced by demented patients. This allows experimenters to use more rigorous 
methodologies and to test the impact of CS in the absence of pharmacological treatment (not normally 
administered to MCI patients). As the most common cognitive problem in MCI is impairment in memory, most 
of the computerised and non-computerised designs have been based on memory exercises and have tried to  
improve this function. The overall pattern of findings is characterised by only sporadic success [61], although 
reviews often report optimistic conclusions [62], and the findings of a meta-analysis of 17 studies, taken 
together, appear to indicate that there might be significant beneficial results in executive functioning, memory 
and overall cognition [63]. A closer look at this meta-analysis reveals considerable variation in the 
methodological and theoretical aspects of the studies examined. Six of the 17 studies had no control group and 
experimental groups ranged from 9 to 67 participants. Moreover, some of the included studies did not have a 
programme with sufficient cognitive signature (occupational therapy, cognitive-behavioural therapy, educational 
programmes). Stott and Spector [61] carried out a second meta-analysis but only included interventions on 
memory. Again, a critical review of available evidence is necessary to understand what the most fruitful 
deployment of CS is likely to be. 
 
A large component of the literature on CS in MCI has studied the effect of training programmes in which 
patients were trained with specific strategies to improve cognitive performance (especially memory). An early 
study describes the effect of a multi-componential protocol lasting 6 weeks and consisting of tutorials teaching 
the use of memory strategies together with relaxation and other forms of non-cognitive stimulation. The 
comparison with a no-contact control group reported no changes in objective measures of memory [64]. A 
similar study was carried out by Troyer and colleagues [65], who planned an educational intervention centred on 
teaching strategies in order to enhance memory in everyday life, but including other various didactic aspects 
such as relaxation and nutrition. Like the former study, no impact on neuropsychological tests of memory was 
reported. In a third study a mixed sample of older adults with subjective memory complaints or objective 
memory impairment was recruited in order to test a 3-month programme of CS based on memory strategies. 
None of the a priori planned statistical comparisons revealed significant changes in cognition, but additional 
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exploratory analyses suggested a positive impact of this type of treatment [66]. A moderately more successful 
attempt was made by a Swedish team, who recruited 15 amnestic single-domain MCI participants and treated 
them with a cognitive strategy-based training for everyday life goals for 8 weeks. No control group was 
included in this study.  No benefit was reported in memory and executive tasks, but an improvement in 
processing speed was registered [67]. More positive findings have been reported by other teams. Eight weeks of 
teaching memory strategies, with complementary exercises for attention and processing speed led to 
improvement in a face-name association task and in verbal delayed recall, in comparison with untreated MCI 
patients [68]. The team of Unverzagt and colleagues [69] tested the effectiveness of a package of strategy-
oriented CS previously tested on an extremely large sample of healthy elderly adults [41, 70] and a smaller 
sample of AD patients [42]. Domain-specific improvements were observed in all the subgroups of MCI patients 
(each subgroup trained with strategies of executive functions, executive speed or memory) in comparison with 
the three control groups who only received a booster training. However, improvements were transferred to none 
of the untrained domains. Moro et al. [71] designed a programme of CS based on the learning of strategies for 
memory and the development of metacognitive competence. They trained MCI patients for 6 months in the 
constant presence of their caregivers. The comparison between the training-dependent change in cognitive 
performance in the experimental group and that in the control group (who received no training) revealed a 
significant and positive impact of the training programme on various measures of attention and verbal memory. 
However, as no post-hoc correction for multiple comparisons was used, a more conservative re-interpretation of 
these findings (and their respective p values) would indicate that memory was the cognitive domain which 
benefited the most from the training.. In a recent study authored by Olchick and colleagues [72], samples of 
MCI and healthy adults were enrolled. Some were taught and exercised with strategies. Two control groups 
were also recruited for each diagnostic group. One only took part in educational sessions about memory and 
ageing, while the other was a no-contact control group. No clear evidence of improvement in objective measures 
of cognition was reported, as the active control group showed changes similar to the experimental group. A 
recent and much shorter intervention was designed by Hampstead and colleagues [73]. They trained MCI 
individuals for 2 weeks with a task in which learning of associations between object and location was requested. 
A structural MRI was also acquired.  Significantly better performance was reported for those MCI participants 
who were taught a mnemonic strategy, compared with those who had a normal exposure to the material but did 
not train with strategies. This change in performance was negatively correlated with the size of the inferior 
lateral ventricles, but did not correlate with the total volume of the lateral ventricles, hippocampi or amygdalae. 
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Finally, results from a study investigating the efficacy of strategy learning for improving memory performance 
were associated with changes in brain function in a sample of 15 MCI patients. Encoding- and retrieval-related 
resources benefitted from training and a rearrangement of activation in a complex pattern of areas was observed 
after only 12 hours of intervention [74]. This indicates that strategy learning triggers quick modifications in 
brain function.  
This corpus of research is characterised by a common interventional framework based on teaching cognitive 
strategies to patients to improve their performance. In educational settings, a strategy is a routine that aims to 
enhance the acquisition and use of knowledge about the world [75]. Strategies can be either task-specific or 
transferrable to other tasks and situations [76]. Although any form of improvement is a desirable goal in MCI 
and dementia, strategies that are generalisable to other domains and settings would be preferred over task-
speficic strategies. However, the set of findings reviewed above suggests that the benefits triggered by strategy 
training in MCI have had limited, or no transfer to other tasks and domains. As a consequence, it is likely that 
most of the strategies taught to MCI patients have been task-specific. In their model, Lövdén and colleagues 
specify that the use of strategies, albeit being able to trigger improvement in performance, does not generate 
neuroplastic changes, because strategy training is based on the use and manipulation of representations (used as 
a synonim for knowledge), and circumvents computational processes [57]. The definitions of representation and 
process are a fundamental distinction in cognitive psychology. 5HSUHVHQWDWLRQVDUH³Hmbodiments or 
LQWHUSUHWDWLRQVRILGHDV´>5@ZKHUHDVSURFHVVHVDUHHQWLWLHVUHTXLUHGWR³KHOSLQNHHSLQJWKHLQWHJULW\RIWKHJRDO
UHSUHVHQWDWLRQ´>7]. There are processes which play a central role in human cognition and are associated with 
the activity of areas and circuits, which, in turn are involved in multiple tasks of diverse nature (e.g. working 
memory and executive functions). Training such processes would facilitate transfer to those untrained tasks 
whose activity is associated with a completely or partially overlappable set of areas [78] (see also [79] for a 
retraction of the published findings. This retraction does not affect the theoretical rationale of the study). On the 
other hand, strategy training would bypass processes and rely on simple acquisition of knowledge and flexibility 
in the use of representations [57]. Based on this view, as intended by the model of Lövdén and colleagues, it 
seems unlikely that changes in brain functions observed after strategy training (i.e. [74]) are the result of 
neuroplastic mechanisms. It is instead suggested that training with strategies facilitates the acquisition and use 
of knowledge about task material so that this ability can be transfered to other tasks (e.g. cognitive tests 
administered at the end of the CS programme) based on similar computations. This, however, does not rule out 
the possibility that a brain in the MCI stage of neurodegeneration has potential for neuroplastic changes. 
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In conclusion, these studies are relevant to AD and MCI patients, as clinically significant improvements in 
memory might be associated with improved quality of life. Improvements in memory performance might not 
always involve any overt mechanisms of neurobiological nature, but would, however, be of dramatic importance 
for variables associated to everyday mood, quality of life and general wellbeing of both patients and caregivers. 
For this reason, any improvement in these non-cognitive, non-neural variables is a clinical success. Since the 
ultimate aim of the scientific study of neurodegenerative disorders is to translate findings into the clinical 
VHWWLQJDK\SRWKHWLFDOFRGHRI³JRRGWUDQVODWLRQDOSUDFWLFH´ZRXOGsuggest measuring these variables within all 
randomised trials of CS with potential benefits in everyday life. 
 
A parallel body of research exists, including trials of CS administered on samples of MCI patients which are not 
centred on the use of strategies but based on exercises intended to stimulate sets of computations, repeatedly. A 
review was published four years ago, reviewing four recent studies of this kind in which CS was implemented 
using computerised material [80]. In the first study reviewed, Gunther et al. [81] reported the findings of a pilot 
study done with a programme of CS based on a German software commercialised in 1992 (Cognition I, version 
3.93 [82])$IWHUZHHNVWKHVDPSOHQRWVSHFLILFDOO\GLDJQRVHGZLWK0&,EXWZLWK³DJH-associated memory 
LPSDLUPHQW´LPSURYHGRQYDULRXVFRJQLWLYHPHDVXUHV, including processing speed, long-term memory and 
learning. There was no control, however. In a second study, two small (n = 10) samples of AD patients with an 
MMSE score higher than 22 (on medication) and MCI patients (not on medication) were administered a 
modified version of the TNP software [83], a software originally developed to treat aphasia. Significant (but 
uncorrected for multiple comparisons) increases in scores on the MMSE, phonemic fluency and Trail Making 
Test-Part B were found in the AD sample after two 4-week periods of treatment spaced out by a 6-week break, 
whilst the MCI group showed a significant increase in the Rivermead Behavioural Memory Test [84]. The same 
software was used by Talassi and colleagues [85] together with occupational and behavioural therapy on a 
sample of MCI and mildly demented patients (MMSE score: 15-23). The only positive impact after 3 weeks was 
an improvement in the delayed recall score of the Rey Figure, but the reported significance would not have 
survived adjustments for multiple comparisons. Finally, in the last of the four studies in the review, Rozzini and 
co-workers [86] also used this same software, to train MCI individuals who were also medicated with one of the 
three available cholinesterase inhibitors. Four weeks of intensive stimulation constituted a block, and three 
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subsequent blocks were administered with two-month inter-block distance. The mix of ChEI treatment and this 
programme which focused on various aspects of cognition led to an improvement in scores on the short story 
recall and the Raven progressive matrices task compared with the drugs-only and the no-treatment groups. The 
TNP software was also used by Galante and colleagues [87] as stimulation material in a further study on a small 
sample of mild AD patients. They were assigned either to the TNP condition or to an aspecific treatment 
consisting of conversational activity. However, after four weeks of training, no significant changes in cognition 
emerged.  
 
Other studies have investigated the benefits of CS in MCI. Training material based on principles of 
neuroplasticity [88-89] was used in a controlled trial by Barnes and colleagues [90] with a sample of MCI 
patients. Positive trends in the predicted direction were reported in several measures of cognition, albeit not 
reaching significance. The authors concluded that larger samples were needed. A Brazilian team tested the 
effectiveness of a CS protocol consisting of memory, attention, proper names retrieval, mental calculation and 
orientation exercises, based on multiple types of exercise, some of which used strategies and required the use of 
external aids [91]. Improvements were reported in various measures of cognition. These findings, however, are 
vitiated by a methodological problem, since participants were treated in parallel with lithium. The study with 
AD patients by Kurz et al. [31] mentioned above also included two groups of MCI participants; one of these 
MCI groups was treated with the same multidimensional protocol administered to the subgroup with dementia. 
Both verbal and non-verbal memory skills improved. More recently, small samples of South Korean AD and 
amnestic MCI patients were treated with a package of multidimensional cognitive stimulation including 
numerous modalities of task. Test-retest improvements were registered in several sub-components of cognition 
albeit these benefits were minimal [92]. Finally, in an Italian study a small sample of MCI patients was treated 
with five sessions of working memory exercises completed over two weeks [93]. Changes were found in the 
working memory target test and in a test of fluid intelligence in comparison with the control group who had five 
educational sessions about memory including advice on the use of strategies. These findings seem to contrast 
with the earlier negative evidence from studies which focused on the effects of strategy usage. When CS does 
not exclusively focus on improving knowledge of training material, it appears to have a larger impact on 
cognitive skills, even though there is no well-defined pattern of consistent findings. 
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All of the above studies suggest that CS may be more easily implemented in samples of patients who have only 
mild cognitive problems and who are not demented. Significant benefits induced by CS indicate that the central 
nervous system of individuals with MCI might retain sufficient neural plasticity to trigger organic changes of 
brain structure and reorganisation of brain function and benefit, therefore, from this type of intervention. This 
hypothesis has been investigated by those teams who have recruited samples of MCI patients and analysed 
changes induced by CS using measures of neuroimaging. To date, we are aware of three studies that report 
alterations of fMRI task-associated activation due to the effect of a programme of CS. The study by Belleville 
and colleagues that reported changes in activation following strategy training [74] has already been discussed 
above with regard to the nature of strategies. Hampstead and colleagues [94] piloted a small CS programme on a 
sample of 6 amnestic multidomain MCI patients (with no control group). Five sessions of face-name association 
training were administered over a period of 2 weeks. The first and the fifth sessions were recorded in the fMRI 
scanner and compared.  Measures of effective connectivity, a parameter similar to functional connectivity, but 
aimed at detecting a causal relationship between the activities of two separate hubs, were used. The authors 
interpreted the wide-spread increase in task-related activation as enhancement of function of structures within 
the default mode network (whose system of interconnected brain structures is disrupted in $O]KHLPHU¶VGLVHDVH, 
with enhanced connectivity between the middle temporal gyrus and precuneus/posterior cingulate and other 
parietal areas. Rosen et al. [95] treated a small sample of MCI patients (of various subtypes, some of them 
treated also with AD-related medication) with the same programme of exercises based on principles of 
neuroplasticity (reviewed above) used by Barnes and colleagues [90]. An intense regime was chosen, with 24 
sessions of individually-tailored difficulty and gradually-increased duration. Efficacy was assessed as a change 
in activation during performance in a verbal encoding task. Increases in activation were reported in the 
hippocampus, suggesting that this area, although being extremely susceptible to AD pathology, still retains 
some residual capacity for plasticity at the MCI stage. These three studies, albeit not representing a substantial 
body of research, suggest that individuals in the MCI stage retain capacity for neural plasticity, and suggest that 
even the changes in cognition reported in studies that did not include neuroimaging recordings may have been 
triggered by neuroplastic effects. More studies are needed to understand what the most effective types of 
exercise are for this diagnostic group, to observe structured changes in neural and cognitive variables and to 
formulate benefit in parameters of clinical relevance, for example an attenuation of cognitive decline, or stable 
levels of cognition over a timespan. 
 
19 
 
The priority of studies with MCI patients has always been given to improving cognition and variables related to 
daily life. Unless they are markedly focused on a specific mechanism, most of the studies have an explicit or 
implicit objective directed towards the improvement of everyday life conditions for patients and caregivers. 
Studying CS with a focus on neuroplasticity would mean identifying structural mechanisms that could be 
modified via training and lead to significant improvements, measurable through analysis of both cognitive 
functions and brain physiological parameters. The literature on changes in brain structure and function due to 
CS is limited, and remarkably no study has specifically investigated changes in brain structure triggered by CS 
in samples of AD or MCI patients. In conclusion there is some evidence suggesting that people in the MCI stage 
still retain capacity for neuroplasticity, but more and more specific evidence is needed from bigger samples and 
with whole-brain methodologies of investigations. 
 
 
Part 3: The Importance of Studies Investigating Cognitive Stimulation in Healthy Individuals 
 
An overview of parallel studies of CS in AD and MCI groups suggests that there is an inverse relation between 
progression of disease severity and the brain¶V retained capacity for plasticity. This would imply that healthy 
individuals should show even greater neurocognitive changes than diseased groups due to neuroplastic 
processes. The population of healthy young and old adults represents the best target groups to test specific 
hypotheses of the effect of forms of non-pharmacological treatment based on neuroplasticity. A large number of 
publications have reported neural changes following CS in samples of healthy individuals. The first studies 
which investigated structural changes triggered by behavioural treatments reported that motor training induced 
regional changes in brain anatomy of both young and old adults [96-97]. Research has then looked at 
programmes of stimulation of cognitive skills. Training based on learning through the use of a cognitive strategy 
was associated with specific cortical thickening [98]. Another team found structural changes with Voxel-Based 
Morphometry (VBM) in young adults after just 5 days of intensive (4 hours every day) cognitive workout [99-
100]. 7KLVLQGLFDWHVWKDWLQ\RXQJKHDOWK\EUDLQVQHXURSODVWLFSURFHVVHVDUHQRWDV³VOXJJLVK´DVinitially 
hypothesised [57]. Diffusion Tensor Imaging (DTI) was also applied to the study of CS in healthy adults, and 
changes in parameters of white matter diffusivity were reported following cognitive interventions [101-102], 
even after training with memory strategies [103]. The use of VBM and DTI in the study of CS in samples of AD 
and MCI may represent an important frontier in the study of the effects of therapeutics in neurodegenerative 
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processes. AD has been associated with specific patterns of atrophy and structural disconnection [104-105]. 
However, no specific study has investigated the effects of CS on structural parameters in the presence or in the 
potential presence of AD pathology. Two studies of healthy participants also found changes in functional 
connectivity following CS [99, 106] and at least two studies have found regional changes in resting-state blood 
flow [107-108]. Similarly, the impact of AD on resting state function and connectivity is well known [54, 109], 
but, as reviewed above, only a few studies have investigated the impact of CS on these parameters. For this 
reason, samples of healthy participants may represent an initial target to test the effectiveness of experimental 
programmes of CS specifically designed to treat patients with MCI or AD. 
 
 
Final Considerations 
 
The study of CS is moving towards models describing changes in brain structure and function that are the result 
of neuroplastic effects [110]. For this reason, the study of CS in AD pathology should move in the same 
direction, incorporating designs with neuroimaging measurements and experimental hypotheses linking 
cognitive exercises with specific mechanisms of neural modifications. Most studies based on neuroimaging 
measures have been explorative and, albeit describing remarkable changes in brain structure and/or function, 
have not detailed the exact mechanism by which the repeated administration of training exercises would 
influence the neural substrate by inducing specific expected changes. Along these lines, participating in 
cognitively stimulating activities has also been reported to be associated with lower Beta Amyloid burden in a 
large set of brain areas [111]. The suggestion that CS might attenuate the pathophysiological burden of AD is 
extremely interesting. In fact, according to this hypothesis, CS could be contextualised as an instrument not 
meant to target cognitive functions or the neural system, but disease processes at the cellular level. Arguably, 
this opportunity would not become a major breakthrough in this literature as long as CS is not designed and 
tested as a function of a specific mechanism based on neuroplasticity. 
 
To date only a few of these mechanisms have been hypothesised. The stimulation of specific neuronal regions 
showing hypometabolism in AD [53] appears to be a reasonable interventional option, as it aims to regulate a 
well-determined process disrupted by the pathology. The use of training material design to target semantic-
lexical networks [55] appears as another option with a strong theoretical motivation, as lexical-semantic 
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difficulties are an early-stage impairment in AD [112]. An opposite approach to these two hypotheses could be 
the stimulation of computational units that are not primarily affected by AD, which could thus represent a 
KHDOWK\VXEVWUDWHWR³IRUWLI\´ retained cognitive skills. Stimulation of procedural memory [113], for instance, 
might reflect the regulation of networks that are affected by AD at later stages. This network regulation, 
however, seems to be more indicated at disease stages in which restorative network regulation (i.e. and up-
regulation of areas with hypometabolism) is no longer possible, and the sole avenue of treatment is either 
compensative or aims to maintain a high level of functionality in the cognitive functions that are relatively 
spared by the disease. However, a comparable approach adopted in the study by Herrera and colleagues [114] 
suggests that a more sophisticated implementation of this rationale (stimulation of preserved functions) may 
lead to benefits even in the prodromal stages of neurodegeneration. These authors designed a computerised 
programme for MCI patients focused on recognition memoryEHLQJWKLVIXQFWLRQ³VWLOOSUHVHUYHGRUVOLJKWO\
LPSDLUHGLQ0&,´SDJH,QWKLVVWXG\the aim was not to stimulate a function relatively spared by AD 
(like procedural memory, supported by implicit memory processes), but rather to exercise a relatively preserved 
form of recollection (recognition), an aspect of this function that relies on explicit memory processes which are 
negatively affected by AD (episodic memory). Although the target of CS was a spared sub-component of 
cognition, improvements generalised even to measures of episodic recall. This finding suggests that training of 
relatively intact cognitive functions can be particularly beneficial in MCI when the network sustaining them 
(sufficiently preserved to allow normal recognition abilities) also supports other functions that are more 
susceptible to AD neuropathology. In addition to the approaches suggested above, there also are studies which 
have explored different perspectives. One study which used a CS approach based on a mechanism specifically 
focused on the auditory channel, suggested that specific exercises might regulate and enhance the pattern of 
neuromodulation (normally down-regulated by ageing) of a series of structures involved in attention, perception, 
and memory [88]. A fifth and final mechanism has been recently proposed by Martinez and colleagues, who 
postulated that resting-state connectivity between two areas might be enhanced by co-activation of those two 
areas induced by specific, muti-componential tasks [115].  
Future studies should attempt to identify new potential mechanisms of CS and should also include the 
appropriate measurement of benefits triggered by this form of intervention, using the most fitting neuroimaging 
techniques, in association with classical testing of cognitive function and, possibly, daily-life functionality. In 
addition, changes in neuropsychological functions should be carefully examined in relation to the nature of the 
training. Indeed, cognitive improvement in AD or MCI partients has been reported almost exclusively in 
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domains directly stimulated by the training exercises. A CS programme inducing significant changes in 
untrained cognitive skills would undoubtedly be a large success. Within the set of neuroimaging variables, 
measures of functional connectivity appear to be particularly indicated in the study of neurodegenerative 
diseases as brain networks appear to be associated with their pathophysiological progression [10]. Within this 
general picture, the identification of a candidate mechanism responsible for neurocognitive improvement would 
also allow the recognition of the main intervenient variables (e.g. cognitive reserve) that may play a significant 
role in modulating treatment effectiveness. 
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Table 1. List (#) of studies which report specifically structured and cognitively based CS programmes included in the review. 
 
Authors Group Number of Participants Methods Use of ChEI Imaging Control (Y/N) 
       
Participants ZLWKSUREDEOH$O]KHLPHU¶VGLVHDVH 
       
CS based on spared functions 
       
Yanguas et al., 2006 
(1st sub-group) Minimal-mild AD 
Not indicated (part of a the 
complete recruited sample of 
390 individuals) 
Training of various cognitive 
functions and ADL 
Not specified 
(reasonably all) No Yes (not described) 
       
Yanguas et al., 2006 
(2nd sub-group) 
Moderate-severe 
AD 
Not indicated (part of a the 
complete recruited sample of 
390 individuals) 
Training of residual cognitive 
abilities and ADL 
Not specified 
(reasonably all) No Yes (not described) 
       
Farina et al., 2002 Mild-moderate AD Experimental sub-group 2 of the 
study: 11 
Training of residual cognitive 
abilities 
Not specified 
(reasonably all) No No 
       
Farina et al., 2006 Mild-moderate AD Experimental sub-group 2 of the 
study: 16 
Training of residual cognitive 
abilities 
Experimental 
sub-group: 11 
out of 16 
No No 
       
Combination of CS and pharmacological treatment (control group not receiving CS) 
       
Giordano et al., 2010 Mild-moderate AD Experimental sub-group: 62             Control sub-group: 38 ROT All No Yes: No treatment 
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Bottino et al., 2005 Mild AD Experimental sub-group: 6            Control sub-group: 7 
ROT, learning, memory, 
communication and ADL 
training 
All No Yes: No treatment 
       
Chapman et al., 2004 Mild-moderate AD Experimental sub-group: 26            Control sub-group: 28 
Communication, functional 
activities and quality of life 
training 
All No Yes: No treatment 
       
Matsuda, 2007 AD Experimental sub-group: 17            Control sub-group: 13 
Fluency, communication, 
verbal learning training All No Yes: No treatment 
       
Matsuda et al., 2010 Mild AD Experimental sub-group: 31            Control sub-group: 18 
Mental control, verbal learning 
and fluency training All No Yes: No treatment 
       
Cassinello et al., 2008 Mild AD Experimental sub-group: 17            Control sub-group: 9 
Reasoning and attention, 
language, praxias, gnosias, 
calculation and association-
ordering training 
All No Yes: No treatment 
       
Fernandez-Calvo et 
al., 2011 Mild AD 
Experimental sub-group: 15            
Control sub-group: 15 
"Big Brain Academy" 
videogame All No Yes: No treatment 
       
Scheckter et al., 2013 Mild AD 
Experimental sub-group 1: 15; 
Experimental sub-group 2: 12; 
Control sub-group: 15 
Training of working memory: 
Manipulation of complex 
material (sub-group 1); 
"Dynamic" training on the self 
as "the highest executive and 
metacogntiive authority" (sub-
group 2) 
All No Yes: No treatment 
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Hwang et al., 2012     
(1st sub-group) Mild AD 
Experimental sub-group: 6      
Control sub-group: 3 
ROT, attention, memory, 
executive functions, 
visuoconstructional skills 
training 
All No Yes: No treatment 
 
      Combination of CS and pharmacological treatment (control group receiving CS) 
 
      
Niu et al., 2010 Mild-moderate AD Experimental sub-group: 16             Control sub-group: 16 
ROT, Fluency, perception and 
memory training All No 
Yes: Educational, 
conversational 
sessions 
       
Cahn-Weiner et al., 
2003 Mild AD 
Experimental sub-group: 17            
Control sub-group: 17 Memory strategies All No 
Yes: Educational 
material 
       
Löwenstein et al., 
2004 Mild AD 
Experimental sub-group: 25            
Control sub-group: 19 
Orientation, learning, attention 
and calculation training All No 
Yes: Recreational 
activities and 
computerised games 
       
Tarraga et al., 2006 Mild AD 
Experimental sub-group: 15               
1st control sub-group: 16             
2nd control sub-group: 12 
Training of various cognitive 
functions, ADL training, 
workshops and "Smartbrain" 
computerised exercises 
All No 
Yes:                  
- 1st sub-group: 
cognitive and ADL 
training, workshops       
- 2nd sub-group: No 
treatment 
       
Galante et al, 2007 Mild AD Experimental sub-group: 7             Control sub-group: 4 
Computerised 
multidimensional cognitive 
stimulation 
All No Yes: Conversational 
activities 
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Gaitan et al., 2013 Multidomain MCI-Mild AD 
Experimental sub-group: 23            
Control sub-group: 16 
Computerised 
multidimensional and pen-and-
paper cognitive stimulation 
Experimental 
sub-group: 3 out 
of 16;          
Control sub-
group: 5 out of 
22 
No 
Yes: 
Multidimensional 
pen-and-paper 
cognitive stimulation 
       
Studies based on evidence of brain function 
       
Kawashima et al., 
2005 Mild-to-severe AD 
Experimental sub-group: 16            
Control sub-group: 16 Reading and arithmetic 
Not specified 
(reasonably all) No Yes: No treatment 
       
Jelcic et al., 2012 Mild AD Experimental sub-group: 20            Control sub-group: 20 Lexical-semantic training None No 
Yes: Creative, 
communication and 
recreational activities 
       
Studies with no control condition/group 
       
Cipriani et al., 2006   
(1st sub-group) Mild AD Experimental sub-group: 10            
Computerised 
multidimensional cognitive 
stimulation 
All No No 
       
Kurz et al., 2009      
(1st sub-group) Mild AD Experimental sub-group: 10            
Multi-componentiall cognitive 
and non-cognitive training 
Not specified 
(reasonably all) No No 
       
       
Participants with Mild Cognitive Impairment 
       
Studies based on cognitive strategies 
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Rapp et al., 2002 MCI Experimental sub-group: 9           Control sub-group: 10 
Metacognitive and memory 
strategy training None No Yes: No treatment 
       
Troyer et al., 2008 MCI Experimental sub-group: 24            Control sub-group: 26 
Strategy training and lifestyle 
education Not specified No Yes: No treatment 
       
Craik et al., 2007 
Aduts with 
subjective/objective 
memory 
impairment 
Experimental sub-group: 29            
Control sub-group: 20 Memory strategy training 
Not specified 
(reasonably 
none) 
No Yes: No treatment 
       
Londos et al., 2008 MCI Experimental sub-group: 15           Memory strategy training None No No 
       
Belleville et al., 2006 Amnestic MCI Experimental sub-group: 20            Control sub-group: 8 Memory strategy training Not specified No Yes: No treatment 
       
Unverzagt et al., 2009 MCI 
Memory sub-group: 703;      
Reasoning sub-group: 699;               
Processing speed sub-group: 
702; Control sub-group: 698 
Strategy training Not specified No Yes: No treatment 
       
Moro et al., 2012 Amnestic MCI Experimental sub-group: 15            Control sub-group: 15 
Metacognitive and memory 
strategy training None No 
Yes: No treatment      
Cross-over design            
(30 participants in 
total) 
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Olchik et al., 2013 MCI 
Experimental sub-group: 16;       
1st control sub-group: 17;          
2nd control sub-group: 14 
Memory Strategies 
Not specified 
(reasonably 
none) 
No 
Yes:                  
- 1st sub-group: 
Educational Material        
- 2nd sub-group: No 
treatment 
       
Hampstead et al., 2011 Amnestic MCI Experimental sub-group: 6        Face-name association 
memory strategy training Not specified Yes No 
       
Hampstead et al., 2012 Amnestic MCI Experimental sub-group: 13       Control sub-group: 14 
Visuo-spatial memory strategy 
training Not specified Yes 
Yes: Exposure to 
training material with 
no strategy learning 
       
Belleville et al., 2011 Amnestic MCI Experimental sub-group: 15          Memory strategy training Not specified Yes No 
       
       
CS based on computational exercises 
       
Gunther et al., 2003 
Patients with age-
associated memory 
impairment 
Experimental sub-group: 19           
Computerised 
multidimensional cognitive 
stimulation 
Not specified 
(reasonably 
none) 
No No 
       
Cipriani et al., 2006   
(2nd sub-group) MCI Experimental sub-group: 10            
Computerised 
multidimensional cognitive 
stimulation 
Not specified 
(reasonably 
none) 
No No 
       
Talassi et al., 2007 MCI Experimental sub-group: 30            Control sub-group: 7 
Computerised 
multidimensional cognitive 
stimultation, ADL and 
behavioural training 
Not specified 
(reasonably 
none) 
No 
Yes: Physical, ADL 
and behavioural 
training 
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Rozzini et al., 2007 MCI 
Experimental sub-group: 15               
1st control sub-group: 22                 
2nd control sub-group: 22 
Computerised 
multidimensional cognitive 
stimulation 
Experimental 
and 1st control 
sub-group 
No 
Yes:                  
- 1st sub-group: only 
ChEI                        
- 2nd sub-group: No 
treatment 
       
Barnes et al., 2009 MCI Experimental sub-group: 22         Control sub-group: 25 
Computerised processing 
speed and accuracy training None No 
Yes: Passive 
computerised tasks 
       
Brum et al., 2009 MCI Experimental sub-group: 16         Control sub-group: 18 
Memory, attention, orientation 
and calculation training, and 
lithium 
Experimental 
sub-group: 4 out 
of 16;          
Control sub-
group: 3 out of 
18 
No Yes: lithium 
       
Kurz et al., 2009      
(2nd and 3rd sub-
grous) 
MCI Experimental sub-group: 18         Control sub-group: 12 
Multi-componentiall cognitive 
and non-cognitive training Not specified No Yes: No treatment 
       
Hwang et al., 2012     
(2nd sub-group) Amnestic MCI 
Experimental sub-group: 6      
Control sub-group: 5 
ROT, attention, memory, 
executive functions, 
visuoconstructional skills 
training 
Not specified 
(reasonably 
none) 
No Yes: No treatment 
Carretti et al., 2013 Amnestic MCI Experimental sub-group: 10        Control sub-group: 10 
Verbal working memory 
training None No 
Yes: Educational 
training on memory 
and memory 
strategies 
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Rosen et al., 2011 MCI Experimental sub-group: 6        Control sub-group: 6 
Computerised processing 
speed and accuracy training 
Not specified 
(eligible, if on 
medication) 
Yes Yes: No treatment 
              
# studies are listed following the order of presentation in text within each subsection 
 
